TickerFactsScreenerDevelopers

Ovid Therapeutics Inc. (OVID) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$31.47M2018: -$45.56M2019: -$51.09M2020: -$51.58M2021: $118.61M2022: -$55.23M2023: -$45.78M2024: -$55.96M2025: -$38.33M-$38.33M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$38.33M+31.5%
2024-$55.96M-22.2%
2023-$45.78M+17.1%
2022-$55.23M-146.6%
2021$118.61M+329.9%
2020-$51.58M-1.0%
2019-$51.09M-12.1%
2018-$45.56M-44.8%
2017-$31.47M—